Acute Coronary Syndrome

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

By

Low hs-cTnI levels may identify patients with CAD who have a low medium-term risk for adverse cardiovascular events.

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

By

Combined treatment with pitavastatin and ezetimibe may be beneficial in patients with acute coronary syndrome and without hypertension for secondary prevention.

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

By

Investigators examined whether influenza is an independent risk factor for the development of acute myocardial infarction.

Racial Disparities in Survival After Acute Myocardial Infarction

Racial Disparities in Survival After Acute Myocardial Infarction

For patients with acute myocardial infarction (AMI), mortality rates differ based on characteristics associated with race.

Some Weather Conditions Linked to Myocardial Infarction Risk

Some Weather Conditions Linked to Myocardial Infarction Risk

Certain weather conditions are associated with an increased risk for myocardial infarction.

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

By

The FDA has approved Invokana (canagliflozin) to reduce the risk of major CV events.

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

By

A novel point-of-care assay was shown to provide results within 15 minutes, thereby facilitating rapid risk stratification of patients with suspected acute MI.

Accelerated Diagnostic Protocol Identifies Low-Risk Patients Without Need for Stress Test, Angiography

Accelerated Diagnostic Protocol Identifies Low-Risk Patients Without Need for Stress Test, Angiography

Implementation of the HEART Pathway is associated with decreased hospitalizations, increased identification of MI at the index visit, and a very low death and MI rate among low-risk emergency department patients with chest pain.

Clinical Practice Guideline for Oxygen Therapy in Hospitalized Patients Published

Clinical Practice Guideline for Oxygen Therapy in Hospitalized Patients Published

For acutely ill patients, an oxygen saturation of no more than 96% should be maintained.

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

By

Coronary computed tomography angiography is a reliable tool to assess long-term cardiovascular risk in suspected CCS.

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

By

Single-stage complete coronary revascularization appears to be superior to culprit-only lesion intervention in multivessel disease ACS.

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

By

Patients recovering from sepsis had an elevated risk for myocardial infarction or stroke in the first 4 weeks after hospital discharge compared to the general population.

Outcomes of Undetected Myocardial Infarction Examined

Outcomes of Undetected Myocardial Infarction Examined

By

Unrecognized MI detected by cardiac magnetic resonance imaging has similar mortality rates over the long term compared with recognized MI.

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

By

There is no difference between heparin and bivalirudin in terms of platelet aggregation or coagulation markers after pretreatment with ticagrelor in patients undergoing PPCI.

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

By

Evidence suggests a possible role for inflammation in the association between MS and myocardial infarction risk.

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

By

Same day hospital discharge has the potential increase the overall value of PCI care and save US hospitals approximately $577 million if implemented more consistently.

Lixisenatide Reduces Macroalbuminuria Risk in ACS With T2DM

Lixisenatide Reduces Macroalbuminuria Risk in ACS With T2DM

Lixisenatide reduces progression of urinary albumin-creatinine ratio in patients with macroalbuminuria

QRS-T Angle Improves Diagnostic Accuracy of NSTEMI, Predicts Mortality Risk

QRS-T Angle Improves Diagnostic Accuracy of NSTEMI, Predicts Mortality Risk

By

The use of the QRS-T angle with standard ECG criteria improved diagnostic accuracy for NSTEMI.

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

By

Angiotensin-converting enzyme inhibitors reduced the incidence of revascularization and major adverse cardiac events, but had no beneficial effect on total deaths or recurrence of myocardial infarction.

Revisiting the Clinical Utility of High Sensitivity Cardiac Troponin I Assays

Revisiting the Clinical Utility of High Sensitivity Cardiac Troponin I Assays

By

The effects of using high-sensitivity cardiac troponin I assays in patients with suspected acute coronary syndrome were assessed.

New Clinical Chemistry Score More Sensitive, Specific Than hs-cTn in ACS

New Clinical Chemistry Score More Sensitive, Specific Than hs-cTn in ACS

A score based on the results of three laboratory tests has higher sensitivity and specificity than cardiac troponin alone for stratifying patients presenting with suspected acute coronary syndrome.

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

By

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

By

Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.

Low Rates of Increasing Statin Doses After MI in Diabetes

Low Rates of Increasing Statin Doses After MI in Diabetes

By

Up-titration to a high-intensity statin occurred in only 37.7% of patients with diabetes after an acute myocardial infarction.

Fewer adverse myocardial events in depressed patients treated with antidepressants after acute coronary syndrome

In this prospective cohort study, depressed patients with acute coronary syndrome who were treated with escitalopram were less likely to have major adverse cardiovascular events than those treated with placebo during a long follow-up period.

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Rapid MI Rule-Out Protocol Outperforms Older Assay

Rapid MI Rule-Out Protocol Outperforms Older Assay

By

The new rapid rule-out for MI protocol had sensitivity and negativity predictive values of 100% and a specificity of 86%.

Acute MI Rates Increased From 2014-2017 During Pregnancy, Puerperium

Acute MI Rates Increased From 2014-2017 During Pregnancy, Puerperium

Rate of acute myocardial infarction occurred at a rate of 1 per 12,400 for those hospitalized during pregnancy, puerperium.

Acute Coronary Syndrome Risk Elevated in Siblings of Patients With RA

Acute Coronary Syndrome Risk Elevated in Siblings of Patients With RA

By

Siblings of patients with rheumatoid arthritis appear to have an increased risk for acute coronary syndrome, which suggests there is a shared susceptibility between the 2 conditions.

Dabigatran May Reduce Major Vascular Complication Risk After Noncardiac Surgery

Dabigatran May Reduce Major Vascular Complication Risk After Noncardiac Surgery

By

Dabigatran may be associated with a risk reduction of major vascular complications in patients who develop a myocardial injury after noncardiac surgery.

Sign Up for Free e-Newsletters